Analyst Consensus ?
ConsensusBuy38 ratings
Bullish3079.0%
Neutral718.4%
Bearish12.6%
FN2 Earnings Intelligence
Citizens Financial Group, Inc. (CFG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Oct 20, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Oct 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 20, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 19, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 19, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 14, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 1, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 17, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 17, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 16, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jan 22, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jan 22, 2026 |
| Raymond James | Outperform | Strong Buy | Downgrade | Jan 7, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 17, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 18, 2024 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Oct 23, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 20, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 12, 2022 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Argus | Buy | Hold | Upgrade | Jul 29, 2019 |
| Macquarie | Outperform | Neutral | Upgrade | Nov 27, 2018 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 22, 2018 |
| Bank of America | Buy | Underperform | Upgrade | Oct 22, 2018 |
| Sandler O'Neill | Buy | Hold | Upgrade | Apr 23, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Sep 14, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Apr 21, 2017 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Nov 29, 2016 |
| Oppenheimer | Market Perform | Outperform | Downgrade | Nov 15, 2016 |
| Wells Fargo | Outperform | Market Perform | Upgrade | May 13, 2016 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 26, 2015 |
| Evercore Partners | Buy | Buy | Maintain | Nov 3, 2014 |
Upside is calculated against the persisted current price $65.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $74 | $65.37 | +13.4% | Oct 27, 2026 |
| Truist Financial | Analyst unavailable | $70 | $64.67 | +7.2% | Oct 20, 2026 |
| Stephens | Matt Olney | $65 | $62.76 | -0.4% | Oct 20, 2026 |
| D.A. Davidson | Peter Winter | $82 | $63.18 | +25.6% | Oct 19, 2026 |
| RBC Capital | Analyst unavailable | $74 | $63.18 | +13.4% | Oct 19, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $63.06 | +33.3% | Oct 19, 2026 |
| Cantor Fitzgerald | Dave Rochester | $78 | $63.3 | +19.5% | Oct 14, 2026 |
| Raymond James | Analyst unavailable | $77 | $64.09 | +18.0% | Oct 6, 2026 |
| UBS | Analyst unavailable | $77 | $64.33 | +18.0% | Oct 5, 2026 |
| Evercore ISI | John Pancari | $78 | $63.76 | +19.5% | Oct 1, 2026 |
| Morgan Stanley | Analyst unavailable | $89 | $64.93 | +36.4% | Sep 28, 2026 |
| Truist Financial | Brian Foran | $77 | $65.49 | +18.0% | Sep 23, 2026 |
| Morgan Stanley | Ryan Kenny | $90 | $70.78 | +37.9% | Sep 8, 2026 |
| Cantor Fitzgerald | Dave Rochester | $84 | $73.46 | +28.7% | Aug 19, 2026 |
| Argus Research | Kevin Heal | $80 | $72.57 | +22.6% | Jul 29, 2026 |
| Truist Financial | Analyst unavailable | $80 | $71.5 | +22.6% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $85 | $74.4 | +30.2% | Jul 17, 2026 |
| Stephens | Matt Breese | $70 | $74.4 | +7.2% | Jul 17, 2026 |
| Robert W. Baird | Analyst unavailable | $75 | $74.4 | +14.9% | Jul 17, 2026 |
| Jefferies | Analyst unavailable | $90 | $74.1 | +37.9% | Jul 16, 2026 |
| Evercore ISI | John Pancari | $80 | $71.7 | +22.6% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $72 | $70.98 | +10.3% | Jul 6, 2026 |
| Truist Financial | Analyst unavailable | $72 | $68.99 | +10.3% | Jun 24, 2026 |
| Evercore ISI | Analyst unavailable | $75 | $66.47 | +14.9% | Apr 21, 2026 |
| D.A. Davidson | Analyst unavailable | $74 | $64.45 | +13.4% | Apr 20, 2026 |
| RBC Capital | Gerard Cassidy | $70 | $64.97 | +7.2% | Apr 17, 2026 |
| Robert W. Baird | Analyst unavailable | $65 | $58.31 | -0.4% | Mar 9, 2026 |
| Evercore ISI | John Pancari | $77 | $66.51 | +18.0% | Feb 5, 2026 |
| Truist Financial | Analyst unavailable | $71 | $62.62 | +8.8% | Jan 26, 2026 |
| Argus Research | Kevin Heal | $72 | $63.64 | +10.3% | Jan 23, 2026 |
| New Street | Analyst unavailable | $73 | $65.43 | +11.8% | Jan 22, 2026 |
| RBC Capital | Analyst unavailable | $67 | $65.07 | +2.7% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $73 | $64.06 | +11.8% | Jan 22, 2026 |
| Jefferies | David Chiaverini | $80 | $64.06 | +22.6% | Jan 21, 2026 |
| Raymond James | David Long | $66 | $62.14 | +1.1% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $69 | $61.2 | +5.7% | Jan 6, 2026 |
| Goldman Sachs | Ryan Nash | $73 | $61.23 | +11.8% | Jan 6, 2026 |
| Barclays | Jason Goldberg | $77 | $59.39 | +18.0% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $63 | $59.59 | -3.5% | Dec 22, 2025 |
| Robert W. Baird | Analyst unavailable | $60 | $58.46 | -8.1% | Dec 11, 2025 |
| Truist Financial | Analyst unavailable | $56 | $48.39 | -14.2% | Oct 17, 2025 |
| Stephens | Q3 EPS | $60 | $50.64 | -8.1% | Oct 16, 2025 |
| UBS | Analyst unavailable | $62 | $53.16 | -5.0% | Oct 7, 2025 |
| Raymond James | Analyst unavailable | $62 | $54 | -5.0% | Oct 7, 2025 |
| Truist Financial | Brian Foran | $58 | $52.98 | -11.1% | Oct 3, 2025 |
| Evercore ISI | Analyst unavailable | $61 | $53.65 | -6.5% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $71 | $53.38 | +8.8% | Sep 29, 2025 |
| Evercore ISI | Analyst unavailable | $57 | $52.27 | -12.7% | Sep 17, 2025 |
| Wells Fargo | Analyst unavailable | $57 | $47.03 | -12.7% | Jul 2, 2025 |
| Argus Research | Kevin Heal | $45 | $36.95 | -31.1% | Apr 24, 2025 |
| Truist Financial | Analyst unavailable | $51 | $41.19 | -21.9% | Mar 21, 2025 |
| Raymond James | David Long | $58 | $44.7 | -11.1% | Jan 21, 2025 |
| D.A. Davidson | Peter Winter | $48 | $42 | -26.5% | Oct 17, 2024 |
| RBC Capital | Gerard Cassidy | $45 | $42.41 | -31.1% | Oct 17, 2024 |
| Citigroup | Keith Horowitz | $50 | $42.41 | -23.4% | Oct 17, 2024 |
| Evercore ISI | John Pancari | $46 | $39.92 | -29.5% | Oct 2, 2024 |
| Morgan Stanley | Manan Gosalia | $50 | $39.2 | -23.4% | Aug 5, 2024 |
| Piper Sandler | Scott Siefers | $48 | $43.5 | -26.5% | Jul 26, 2024 |
| Morgan Stanley | Manan Gosalia | $41 | $40.92 | -37.2% | Jul 17, 2024 |
| Piper Sandler | Scott Siefers | $41 | $35.15 | -37.2% | Apr 26, 2024 |
| Wedbush | David Chiaverini | $35 | $33.05 | -46.4% | Apr 18, 2024 |
| UBS | Erika Najarian | $40 | $35.12 | -38.7% | Apr 4, 2024 |
| Morgan Stanley | Betsy Graseck | $33 | $26.96 | -49.4% | Aug 25, 2023 |
| Robert W. Baird | David George | $44 | $27.97 | -32.6% | May 23, 2023 |
| Barclays | Analyst unavailable | $57 | $39.37 | -12.7% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $47 | $38.64 | -28.0% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $53 | $41.7 | -18.8% | Dec 5, 2022 |
| Goldman Sachs | Analyst unavailable | $41 | $34.45 | -37.2% | Oct 3, 2022 |
| Deutsche Bank | Analyst unavailable | $50 | $39.12 | -23.4% | Sep 12, 2022 |
| Barclays | Jason Goldberg | $54 | $37.97 | -17.3% | Jul 31, 2022 |
| RBC Capital | Analyst unavailable | $55 | $36.27 | -15.7% | Jul 7, 2022 |
| Stephens | Analyst unavailable | $48 | $35.83 | -26.5% | Jun 13, 2022 |
| Goldman Sachs | Analyst unavailable | $49 | $40.87 | -24.9% | May 31, 2022 |
| Wolfe Research | Analyst unavailable | $33 | $39.6 | -49.4% | May 26, 2022 |
| Deutsche Bank | Matt O'Connor | $56 | $51.7 | -14.2% | Jan 28, 2022 |
| Credit Suisse | Susan Roth Katzke | $50 | $50.72 | -23.4% | Jan 24, 2022 |
| Citigroup | Jill Shea | $65 | $55.21 | -0.4% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $62 | $48.77 | -5.0% | Jan 3, 2022 |
| Bank of America Securities | Ebrahim Poonawala | $52 | $42.92 | -20.3% | Jul 21, 2021 |
| Evercore ISI | John Pancari | $50 | $48.68 | -23.4% | May 28, 2021 |
| Piper Sandler | Kevin Barker | $54 | $48.86 | -17.3% | May 27, 2021 |
| Compass Point | Dave Rochester | $55 | $48.42 | -15.7% | May 18, 2021 |
| Argus Research | Kevin Heal | $50 | $43.15 | -23.4% | Apr 19, 2021 |
Track every rating change on CFG the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.